✦ LIBER ✦

Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: A double-blind, randomized, controlled trial

✍ Scribed by Debin Lu; Bing Chen; Ziwen Liang; Wuquan Deng; Youzhao Jiang; Shufa Li; Jing Xu; Qinan Wu; Zhonghui Zhang; Bing Xie; Sihao Chen

Book ID: 116407010
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 722 KB
Volume: 92
Category: Article
ISSN: 0168-8227
DOI: 10.1016/j.diabres.2010.12.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, controlled study of autolo

A randomized, controlled study of autologous therapy with bone marrow–derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia

✍ Emerson C. Perin; Guilherme Silva; Amir Gahremanpour; John Canales; Yi Zheng; Ma 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

## Abstract Objectives: The safety and efficacy of direct intramuscular injections of aldehyde dehydrogenase bright (ALDH^br^) cells isolated from autologous bone marrow mononuclear cells (ABMMNCs) and ABMMNCs were studied in patients with critical limb ischemia (CLI) who were not eligible for perc

Therapeutic angiogenesis for patients wi

Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial

✍ E. Tateishi-Yuyama; H. Matsubara; T. Murohara 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Rationale and design of the JUVENTAS tri

Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia

✍ Ralf W. Sprengers; Frans L. Moll; Martin Teraa; Marianne C. Verhaar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 380 KB

Interim analysis results from the RESTOR

Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia

✍ Richard J. Powell; Anthony J. Comerota; Scott A. Berceli; Raul Guzman; Timothy D 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 881 KB

Rationale and design for TIME: A phase I

Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction

✍ Jay H. Traverse; Timothy D. Henry; Douglas E. Vaughn; Stephen G. Ellis; Carl J. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 158 KB